| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0277-5379(85)90018-5 |
| P698 | PubMed publication ID | 2934259 |
| P2093 | author name string | J de Vries | |
| H M Pinedo | |||
| J M van Maanen | |||
| M V Lafleur | |||
| C de Ruiter | |||
| P R Kootstra | |||
| J Retèl | |||
| P433 | issue | 10 | |
| P921 | main subject | etoposide | Q418817 |
| P304 | page(s) | 1215-1218 | |
| P577 | publication date | 1985-10-01 | |
| P1433 | published in | European Journal of Cancer & Clinical Oncology | Q27710832 |
| P1476 | title | Inactivation of phi X174 DNA by the ortho-quinone derivative or its reduction product of the antitumor agent VP 16-213 | |
| P478 | volume | 21 |
| Q39523026 | Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics |
| Q39768346 | Pharmacokinetics of anticancer drugs in children |
| Q41873946 | Role of the semi-quinone free radical of the anti-tumour agent etoposide (VP-16-213) in the inactivation of single- and double-stranded phi X174 DNA. |
| Q40694954 | Simultaneous determination of etoposide and its catechol metabolite in the plasma of pediatric patients by liquid chromatography/tandem mass spectrometry |
| Q78001382 | Simultaneous quantitation of etoposide and its catechol metabolite in human plasma using high-performance liquid chromatography with electrochemical detection |
| Q39658304 | The clinical pharmacology of etoposide and teniposide |
Search more.